1. National cancer database analysis of outcomes in pediatric glioblastoma
   Meng Liu et al, 2018, Cancer Medicine CrossRef
2. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li–Fraumeni family
   Sonja Kappel et al, 2015, Breast Cancer Research and Treatment CrossRef
3. DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives
   Öykü Gönül Geyik et al, 2022, Cells CrossRef
4. Synergy between Auraptene, Ionizing Radiation, and Anticancer Drugs in Colon Adenocarcinoma Cells
   Mahdi Moussavi et al, 2017, Phytotherapy Research CrossRef
5. Iron Oxide Nanoparticles in Cancer Treatment: Cell Responses and the Potency to Improve Radiosensitivity
   Maria V. Shestovskaya et al, 2023, Pharmaceutics CrossRef
6. Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic radiotherapy
   Jonas Högberg et al, 2014, EJNMMI Research CrossRef
7. Plasma checkpoint protein 1 (Chk1) as a potential diagnostic biomarker for opisthorchiasis and cholangiocarcinoma
   Teva Phanaksri et al, 2022, Cancer Biomarkers CrossRef
8. Transglutaminase 2 Inhibitor KCC009 Induces p53-Independent Radiosensitization in Lung Adenocarcinoma Cells
   Sheng Huaying et al, 2016, Medical Science Monitor CrossRef
9. Etoposide radiosensitizes p53-defective cholangiocarcinoma cell lines independent of their G2 checkpoint efficacies
   Arunee Hematulin et al, 2018, Oncology Letters CrossRef